Interestingly, BACE1 inhibition, with a selective chemical inhibitor MK-8931, reprogrammed the tumor-promoting macrophages into tumor-suppressive macrophages that promoted phagocytosis of glioma cells [11]. This evidence concerns the gene BACE1 and neoplasm.